Related Experiment Videos
Vertically acquired paediatric coinfection with HIV and hepatitis C virus
Kirsty England1, Claire Thorne, Marie-Louise Newell
1Centre for Paediatric Epidemiology and Biostatistics, Institute of Child Health, University College London, London, UK.
Insights
HIV and hepatitis C virus (HCV) coinfection in children born to infected mothers requires further study. Understanding how coinfection impacts disease progression and treatment effectiveness is crucial for managing these vertically transmitted infections.
Area of Science:
- Pediatric Infectious Diseases
- Hepatology
- Virology
Background:
- HIV and Hepatitis C Virus (HCV) can be transmitted from mother to child.
- Vertical transmission of both HIV and HCV is less common than individual infections.
- The impact of HCV coinfection on HIV progression in children is not well understood.
Purpose of the Study:
- To investigate the effects of HIV coinfection on HCV progression in children.
- To determine if HCV coinfection affects the success of pediatric HIV treatment.
- To address knowledge gaps in managing vertically acquired HIV/HCV coinfection.
Main Methods:
- Review of existing literature on vertically transmitted HIV/HCV coinfection.
- Analysis of pediatric patient data (where available).
- Assessment of treatment interactions and contraindications for coinfected children.
Main Results:
- HCV coinfection's effect on HIV progression in children is largely unknown.
- HIV coinfection's impact on HCV progression in children is based on limited data.
- Co-administration of HIV and HCV therapies presents challenges due to interactions and toxicity.
Conclusions:
- Further research is essential to understand HIV/HCV coinfection in vertically infected children.
- Effective management strategies and treatment trials for coinfected children are needed.
- Focus on vertically acquired coinfection is critical for informing future pediatric treatment guidelines.
Abstract:
Both HIV and hepatitis C virus (HCV) can be transmitted from mother to child during pregnancy and delivery. Vertical transmission of HIV and HCV separately is most likely from HIV/HCV-coinfected mothers; however, transmission of both infections is less frequent. The effect of HCV coinfection on HIV-related disease remains unclear; whereas most studies indicate no effect, recent results suggest HCV in adults accelerates HIV progression. Little is known about how HIV coinfection affects HCV progression in children and the information available is based on small numbers of patients. Paediatric HIV treatment is extremely successful and it is vital to determine if HCV coinfection alters the effectiveness of this treatment. The hepatotoxicity of many HIV therapies and the possible negative impact of HCV on this treatment, alongside the interactions and contraindications of many HIV and HCV therapies, further limits the choice of paediatric treatments for coinfected children. Future research must therefore focus on vertically acquired HIV/HCV coinfection to inform treatment trials addressing coinfection management.
Related Concept Videos
Cytomegalovirus Disease
Retrovirus Life Cycles
Hepatitis
Cryptococcal Meningitis
Viral Hepatitis I: Introduction
Sexually Transmitted Infections